Angela Lee Diversion Investigators DRUG ENFORCEMENT ADMINISTRATION Jackson, Mississippi

Size: px
Start display at page:

Download "Angela Lee Diversion Investigators DRUG ENFORCEMENT ADMINISTRATION Jackson, Mississippi"

Transcription

1 DRUG ENFORCEMENT ADMINSTRATION Guide to Prescription Fraud &Diversion

2 Angela Lee Diversion Investigators DRUG ENFORCEMENT ADMINISTRATION Jackson, Mississippi

3 Office of Diversion Control Regulatory and Administrative Responsibility Investigative Responsibility for enforcement of the Unites States Code (criminal or civil) and the Code of Federal Regulations

4 DEA s Dual Role Maintain closed system of controlled substance and listed chemical record keeping... Conduct investigations on the diversion of controlled substances and listed chemicals into the black market...

5 WHAT IS DIVERSION THE DIVERTING OF LEGITMATE CONTROLLED SUBSTANCES or LISTED CHEMICALS INTO THE BLACK MARKET; GOVERNED BY FEDERAL LAW/DEA AUTHORITY; ALSO GOVERNED BY STATE LAW;

6 CONTROLLED PREMISES DEFINITION controlled via CFRs DEA AUTHORITY CONTROLLED PREMISE AND REGISTERED LOCATION ARE THE SAME

7 PRESCRIPTION REFILLS SCHEDULE 3, 3N,4, 4N, AND 5 ORIGINAL Rx WITH 5 REFILLS IN A 6 MONTH PERIOD IS ALLOWED PRESCRIPTION CAN BE TELEPHONED

8 Controlled Substance Dispensing vs. Administering Federal Requirement - Follow state laws and regulations DEA Registration must concur with state authorized activities...

9 Acquiring by Fraud, Deceit, etc. Forged Prescriptions Altered prescriptions False called in prescriptions Doctor Shopping /acquire large amounts The attempt establishes criminal intent and is a chargeable crime

10 Types of Fraudulent Prescriptions Stolen Rx Pads (Charity Hospital, etc.) Altered Rx s Altered physician call back number False call-in Rx s by suspects Computer generated Rx s atsuspects home

11 INDICATIONS THAT RX S ARE NOT LEGITIMATE AMOUNT HIGHER THAN USUAL REFILLS ARE BEING ACQUIRED SOONER THAN THE AMOUNT IS PRESCRIBED FOR SUSPECT PRESENTS RX S IN THE NAMES OF OTHER PERSONS

12 CHARECTERISTICS OF FORGED RX S RX LOOKS TOO GOOD / TOO LEGIBLE QUANTITIES OR DOSAGES DIFFER FROM USUAL MEDICAL DOSAGES RX DOESN T HAVE THE USUAL ABREVEATIONS RX APPEARS TO BE PHOTOCOPIED RX WRITTEN IN DIFFERENT COLOR INKS OR APPEAR TO HAVE DIFFERENT HANDWRITING

13 Title 21 United States Code Illegal distribution 841(a)(1) Illegal Dispensing for registrants using their professional authority to participate, aid and assist in the diversion of pharmaceuticals

14 Title 21 United States Code 843(a)(3) Acquisition of Controlled Substances by Fraud, etc; Federal law may not be applied below minimum threshold amounts; State t law will apply in most cases since each state can effect laws that are more restrictive ti than the federal law - Constitutional Sovereignty

15 Possession of Rx Form For a Controlled Substance or Legend Drug; Legend Drug is one which is not controlled, o but requires es a Rx to be filled Verify Ownership Suspect must have the express consent of the person in whose name the Rx was written for...

16 PAIN MANAGEMENT PRACTITIONERS ARE NOT LIMITED LEGITIMATE MEDICAL PURPOSE *STATED TREATMENT GOALS AND FOLLOW-UP DEA INVESTIGATIONS DR. SHOPPERS/ OBTAINING BY FRAUD SCAMS

17 Myth of the Chilling Effect Vast Majority of Practioners Comply with rules and regulations DEA Investigations are based on facts determined from said investigations... Since FY 1999: Approx. one million registered doctors - DEA has had sanctions pursued upon less than one tenth of 1%...

18 NTP S RELIEF OF PAIN METHADONE SUBJECT TO HIGH ABUSE SCHEDULE II 40mg Diskettes voluntarily removed from marketplace due to abuse provided only to NTPs; Not FDA approved for pain mgt.

19 NTP GUIDELINES FOR M.D. S 3 DAY RULE ADJUNCT TO MEDICAL TREATMENT ADMINISTERED NOT PRESCRIBED Buprenorphine products can be prescribed or administered by authorized physicians

20 INTERNET PRESCRIBING DR. / PATIENT RELATIONSHIP SUBJECT TO ABUSE NEGATIVE PUBLICITY LICENSURE IN ALL JURISDICTIONS WHERE PATIENTS ARE LOCATED

21 POTENTIAL HEALTH RISKS IN INTERNET PRESCRIBING Adverse drug reactions/interactions Misdiagnosis or delay in diagnosis Failure to identify complicating conditions

22 WHERE TO GATHER INFORMATION FOR INVESTIGATION RX FORM REQUIREMENTS RX BOTTLE LABELS VERIFY SUSPECT STORY/MAKE TELEPHONE INQUIRIES FACE TO FACE INTERVIEW WITH PHYSICIAN AND STAFF WHEN POSSIBLE INTERVIEW OF PHARMACIST AND STAFF WHEN POSSIBLE

23 On Scene Investigation Do the basics of verifying Rx with physician Get statement from pharmacist and physician Verify DEA Registration Number Get actual RX form for evidence from pharmacy Verify handwriting (handwriting exemplar) Get written disclaimer on Rx form from DR.

24 Acquiring Documentary Evidence at Pharmacies Subpoena Deuces Tecum from District Attorney s Office Pres. Monitoring Prog. Ask for DEA assistance if possible - Service of Notice of Inspection Grand Jury Subpoenas Always provide a receipt for any documents taken as evidence; return documents upon completion of prosecution...

25 Common Characteristics of the Drug Abuser Unusual behavior in the waiting room Assertive personality, often demanding immediate service Unusual appearance, extreme slovenliness or over dressed d May have unusual knowledge of controlled substances or gives medical history with textbook symptoms or gives evasive or vague answers to questions on their medical history

26 Characteristics Continued Reluctant or unwilling to provide information, usually has no regular doctor or health insurance, pays in cash Will request specific controlled substances by name, and won t try a different drug\ Has no interest in diagnosis, fails to keep appointments, t refuses to see a specialists May exhibit mood swings, suicidal thoughts, lack of impulse control

27 MO Used by Drug Abusers Must be seen right away, anxious, nervous Wants an appointment at the end of the day Calls or comes in after regular hours Traveling through town, visiting friends or relatives, not a permanent resident Feigning physical problems, such as abdominal or back pain, kidney stones, migraine headaches

28 MO Continued Feigning psychological problems, anxiety, insomnia, fatigue or depression States that specific non-narcotic narcotic analgesics don t work or they are allergic to them Claims to be a patient of a practitioner who is not available or they will not give the name of their primary physician

29 MO Continued Claims a prescription has been lost or stolen Requests early refills Pressures the practitioner with sympathy or guilt or direct threats t Uses a child or elderly person when seeking methylphenidate or pain medication

30 What to do When Confronted by DO: a Suspected Drug Abuser Perform a thorough examination appropriate to the condition Document examination results and questions you asked the patient t Request a picture ID and social security number, photocopy and keep in medical file Call a previous practitioner, pharmacist or hospital to confirm the patient s story

31 DO Continued Confirm telephone number of patient Confirm current address of patient Write Wit prescriptions for a limited it amount Limit refills

32 What not to do DON T Take the patients word for it Dispense drugs just to get rid of drug seeking patients Prescribe, dispense or administer controlled substances outside the scope of your professional practice or in the absence of a practitioner-patient patient relationship

33 Responsibilities Legal and ethical responsibility to uphold the law and protect society from drug abuse Professional responsibility to prescribe and dispense controlled substances appropriately Personal responsibility to protect t your practice from becoming easy target

34 Potential Penalties Letter of Admonition Civil Fines Ci Criminal i lp Prosecution Revocation

35 For Further Information, contact the: Jackson District Office Diversion Group Contact Us at: (601) or jg

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

Federal Regulations For Prescribing Scheduled Controlled Substances

Federal Regulations For Prescribing Scheduled Controlled Substances Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system

More information

Narcotic Treatment Programs

Narcotic Treatment Programs This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act

More information

12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT

12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code

More information

2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program

2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program PMP Center of Excellence Notes from the Field 2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program January 2011 This project was supported by Grant No. 2006-DG-BX-K071

More information

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions

More information

CHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No.

CHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. CHAPTER 2010-211 Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. 2722 An act relating to controlled substances; amending s. 456.037,

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Medicare Compliance and Fraud, Waste, and Abuse Training

Medicare Compliance and Fraud, Waste, and Abuse Training Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques

More information

13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT

13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of

More information

MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING

MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING 2 0 1 4 Introduction The Medicare and Medicaid programs are governed by statutes, regulations, and policies PacificSource must have an effective

More information

DEA Washington Division Diversion Control Program

DEA Washington Division Diversion Control Program SOUTHWEST VIRGINIA PRESCRIPTION DRUG ABUSE SUMMIT DEA Washington Division Diversion Control Program Mary Johnson-Rochee Diversion Program Manager November 14, 2012 Topics: DEA s Diversion Mission How DEA

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010 Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an

More information

What Every Practitioner Needs to Know About Controlled Substance Prescribing

What Every Practitioner Needs to Know About Controlled Substance Prescribing What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of

More information

Developed by the Centers for Medicare & Medicaid Services

Developed by the Centers for Medicare & Medicaid Services Developed by the Centers for Medicare & Medicaid Services Every year millions of dollars are improperly spent because of fraud, waste, and abuse. It affects everyone. Including YOU. This training will

More information

How To Get A Prescription In Rhode Island

How To Get A Prescription In Rhode Island Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.

More information

1) ELIGIBLE DISCIPLINES

1) ELIGIBLE DISCIPLINES PRACTITIONER S APPLICABLE TO ALL INDIVIDUAL NETWORK PARTICIPANTS AND APPLICANTS FOR THE PREFERRED PAYMENT PLAN NETWORK, MEDI-PAK ADVANTAGE PFFS NETWORK AND MEDI-PAK ADVANTAGE LPPO NETWORK. 1) ELIGIBLE

More information

SUBCHAPTER IV. OFFENSES AND PENALTIES

SUBCHAPTER IV. OFFENSES AND PENALTIES DISTRICT OF COLUMBIA OFFICIAL CODE TITLE 48. FOOD AND DRUGS SUBTITLE III. ILLEGAL DRUGS CHAPTER 9. CONTROLLED SUBSTANCES UNIT A. CONTROLLED SUBSTANCES ACT SUBCHAPTER IV. OFFENSES AND PENALTIES 48-904.01.

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

SCOPE OF PRACTICE FOR ARNPS

SCOPE OF PRACTICE FOR ARNPS FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow

More information

Fraud, Waste, and Abuse

Fraud, Waste, and Abuse These training materials are divided into three topics to meet the responsibilities stated on the previous pages: Fraud, Waste, Compliance Program Standards of Conduct Although the information contained

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

Drug-Free Workplace Policy and Procedures July 16, 2015

Drug-Free Workplace Policy and Procedures July 16, 2015 Drug-Free Workplace Policy and Procedures July 16, 2015 Regional Transit Authority of Southeast Michigan Drug-Free Workplace Policy and Procedures Purpose In compliance with regulations governing anti-drug

More information

CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS

CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD Kelly Raker 310 Ezzard Charles Dr. Cincinnati, OH 45214 513-564-2233

More information

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:

More information

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department

More information

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related entities

More information

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate

More information

POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL

POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL PURPOSE POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL To outline the procedures used in recognizing and providing

More information

INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS

INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND DISCLOSURE SHERRY L. GREEN, CEO NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS NATIONAL CONFERENCE OF

More information

Electronic Prescribing In New York State

Electronic Prescribing In New York State Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe

More information

Do You Know Where the Drugs Are Going?

Do You Know Where the Drugs Are Going? Do You Know Where the Drugs Are Going? Presentation Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at least four

More information

"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee

Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities Before the Senate Judiciary Committee DEA Congressional Testimony December 4, 2007 Statement of Joseph T. Rannazzisi Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration "Electronic Prescribing of Controlled

More information

1 st Tier & Downstream Training Focus

1 st Tier & Downstream Training Focus Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste

More information

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322 LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING

More information

5530 SUBSTANCE ABUSE (M)

5530 SUBSTANCE ABUSE (M) Haddonfield 5530 / Page 1 of 10 5530 SUBSTANCE ABUSE (M) The following procedures are established in implementation of Policy No. 5530, Substance Abuse. A. Definitions 1. Evaluation means those procedures

More information

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

Fraud Waste and Abuse Training Requirement. To Whom It May Concern: RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)

More information

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy

More information

TEXAS ~ STATUTE Continued

TEXAS ~ STATUTE Continued TEXAS ~ STATUTE STATUTE DATE Enacted 1981 REGULATORY BODY Texas Rev. Civ. Stat., Occupations Code, Chapter 204: Physician Assistant Licensing Act; Occupations Code Chapter 157; Authority of Physician to

More information

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies 2008 Medco Health Solutions, Inc. All rights reserved. Training Introduction In this training, you ll learn

More information

HP1616, LD 2253, item 1, 123rd Maine State Legislature An Act To License Certified Professional Midwives

HP1616, LD 2253, item 1, 123rd Maine State Legislature An Act To License Certified Professional Midwives PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney. Be it enacted by the People of the

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011

Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your

More information

How To Deal With A Pupil Who Is Under The Influence Of Alcohol Or Drugs

How To Deal With A Pupil Who Is Under The Influence Of Alcohol Or Drugs R 5530/Page 1 of 12 R 5530 The following procedures are established in implementation of Policy No. 5530, Substance Abuse. A. Definitions 1. Evaluation means those procedures used by a certified or licensed

More information

Arkansas Emergency Department Opioid Prescribing Guidelines

Arkansas Emergency Department Opioid Prescribing Guidelines Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular

More information

"HAWAII ADMINISTRATIVE RULES TITLE 11 DEPARTMENT OF HEALTH CHAPTER 160 MEDICAL USE OF MARIJUANA. Debilitating Medical Conditions

HAWAII ADMINISTRATIVE RULES TITLE 11 DEPARTMENT OF HEALTH CHAPTER 160 MEDICAL USE OF MARIJUANA. Debilitating Medical Conditions "HAWAII ADMINISTRATIVE RULES TITLE 11 DEPARTMENT OF HEALTH CHAPTER 160 MEDICAL USE OF MARIJUANA Subchapter 1 General Provisions 11-160-1 Purpose 11-160-2 Definitions 11-160-3 Severability 11-160-4 Disclaimer

More information

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority: Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain

More information

Physician Information. Answers to Frequently Asked Questions

Physician Information. Answers to Frequently Asked Questions Page 31 Physician Information Answers to Frequently Asked Questions Who is qualified to prescribe SUBOXONE or SUBUTEX? Physicians who: Meet one or more of the following training requirements Hold a subspecialty

More information

Do You Know Where the Drugs Are Going? Partners in Integrity

Do You Know Where the Drugs Are Going? Partners in Integrity Do You Know Where the Drugs Are Going? Partners in Integrity Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at

More information

Touchstone Health Training Guide: Fraud, Waste and Abuse Prevention

Touchstone Health Training Guide: Fraud, Waste and Abuse Prevention Touchstone Health Training Guide: Fraud, Waste and Abuse Prevention About the Training Guide Touchstone is providing this Fraud, Waste and Abuse Prevention Training Guide as a resource for meeting Centers

More information

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System 0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill

More information

2013 Medicare. Part D Fraud, Training. First Tier, Downstream and Related Entities

2013 Medicare. Part D Fraud, Training. First Tier, Downstream and Related Entities 2013 Medicare Advantage and Part D Fraud, Waste and Abuse Waste, Training First Tier, Downstream and Related Entities February, 2013 Training Objectives 1 Why is Fraud, Waste, and Abuse (FWA) Training

More information

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN Janice K. Brewer Governor Arizona State Board of Nursing 4747 North 7 th Street, Suite 200 Phoenix, AZ 85014-3655 Phone (602) 889-5150 Fax - (602) 889-5155 E-Mail: arizona@azbn.gov Home Page: http://www.azbn.gov

More information

Adopted Rule - 11/19/14 1

Adopted Rule - 11/19/14 1 Adopted Rule - 11/19/14 1 CHAPTER Ph 800 PHARMACY TECHNICIANS Statutory Authority: RSA 318:5-a, X, XI Adopt Ph 801 & Ph 802, previously effective 7-25-01 (Doc. # 7535) and expired on 7-25-09, to read as

More information

DEA REGISTRATION FEES FACT SHEET

DEA REGISTRATION FEES FACT SHEET DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants

More information

Manitoba Prescribing Practices Program Pharmacist Questions and Answers

Manitoba Prescribing Practices Program Pharmacist Questions and Answers College of Pharmacists of Manitoba 200 Tache Avenue, Winnipeg, Manitoba R2H 1A7 Phone (204) 233-1411 Fax: (204) 237-3468 E-mail: info@cphm.ca Website: www.cphm.ca Manitoba Prescribing Practices Program

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

NEW/RENEWAL APPLICATION FOR PAIN MANAGEMENT CLINIC REGISTRATION

NEW/RENEWAL APPLICATION FOR PAIN MANAGEMENT CLINIC REGISTRATION Department of Regulatory and Economic Resources Business Affairs Division Office of Consumer Protection 601 NW 1st Court, 18th Floor Miami, Florida 33136 Tel: 786-469-2300 Fax: 786-469-2311 email: license@miamidade.gov

More information

R 5530 SUBSTANCE ABUSE (M) [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204]

R 5530 SUBSTANCE ABUSE (M) [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204] R 5530/Page 1 of 17 M R 5530 [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204] The following procedures are established in implementation of Policy 5530, Substance Abuse. A. Definitions

More information

MEMORANDUM. Employees. Human Resources AGENCY DRUG-FREE WORKPLACE POLICY

MEMORANDUM. Employees. Human Resources AGENCY DRUG-FREE WORKPLACE POLICY MEMORANDUM TO: FROM: RE: Employees Human Resources AGENCY DRUG-FREE WORKPLACE POLICY Attached is a copy of the Mississippi Department of Health s established Drug-Free Workplace Policy. This policy reflects

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS

DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS 855-025-0001 DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS Purpose and Scope Transition from Registration of Technician to Licensure of Technician The purpose of the Pharmacy

More information

A BILL FOR AN ACT ENTITLED: "AN ACT ALLOWING A TERMINALLY ILL PATIENT TO REQUEST

A BILL FOR AN ACT ENTITLED: AN ACT ALLOWING A TERMINALLY ILL PATIENT TO REQUEST SB00.0 SENATE BILL NO. 0 INTRODUCED BY DICK BARRETT A BILL FOR AN ACT ENTITLED: "AN ACT ALLOWING A TERMINALLY ILL PATIENT TO REQUEST MEDICATION TO END THE PATIENT'S LIFE; ESTABLISHING PROCEDURES; PROVIDING

More information

Robbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12

Robbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12 R Robbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12 R 5530 SUBSTANCE ABUSE (M) The following procedures are established in implementation

More information

Pitfalls of Working in Family Medicine Presented by:

Pitfalls of Working in Family Medicine Presented by: Pitfalls of Working in Family Medicine Presented by: www.thehealthlawfirm.com Main Office: 1101 Douglas Avenue Altamonte Springs, Florida 32714 Phone: (407) 331-6620 Fax: (407) 331-3030 Website: www.thehealthlawfirm.com

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Pharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary

Pharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary Pharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary Houston DEA Pharmacy Diversion Awareness Conference September 8 & 9, 2012

More information

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2577. HB 2577 would create the Addictions Counselor Licensure Act. The following is the outline of the Act:

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2577. HB 2577 would create the Addictions Counselor Licensure Act. The following is the outline of the Act: Corrected SESSION OF 2010 SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2577 As Amended by House Committee on Health and Human Services Brief* HB 2577 would create the Addictions Counselor Licensure Act. The following

More information

THE DOG ATE MY PRESCRIPTION! DRUG-SEEKING BEHAVIORS EVERY NURSE SHOULD KNOW Jill Hasley, MNSc., RN

THE DOG ATE MY PRESCRIPTION! DRUG-SEEKING BEHAVIORS EVERY NURSE SHOULD KNOW Jill Hasley, MNSc., RN THE DOG ATE MY PRESCRIPTION! DRUG-SEEKING BEHAVIORS EVERY NURSE SHOULD KNOW Jill Hasley, MNSc., RN What s the Problem? Los Angeles Times (2010): 57% of drug overdoses involved prescription drugs 74% of

More information

Generic and Brand Name Drugs: Understanding the Basics

Generic and Brand Name Drugs: Understanding the Basics Generic and Brand Name Drugs: Understanding the Basics We ve been there. We can help. Joe has just been diagnosed with bipolar disorder. After talking to his doctor, he decides to see a therapist and go

More information

155 McDonald Drive SW Shirley E. Charette, MS, PA-C

155 McDonald Drive SW Shirley E. Charette, MS, PA-C LAKELAND FAMILY MEDICINE Dennis J. Charette, M.D. 155 McDonald Drive SW Shirley E. Charette, MS, PA-C Carri A. Meiler, MS, PA-C Phone: 330-308-8999 Fax: 330-308-8016 www.lakelandfamilymedicine.com PATIENT

More information

ADMINISTRATION OF MEDICATIONS POLICY

ADMINISTRATION OF MEDICATIONS POLICY Policy 6.007. ADMINISTRATION OF MEDICATIONS POLICY It is the policy of Cooperative Educational Services (C.E.S.) that students who require any medications to be administered during school hours, including

More information

CMS Mandated Training for Providers, First Tier, Downstream and Related Entities

CMS Mandated Training for Providers, First Tier, Downstream and Related Entities CMS Mandated Training for Providers, First Tier, Downstream and Related Entities I. INTRODUCTION It is the practice of Midwest Health Plan (MHP) to conduct its business with the highest degree of ethics

More information

ACTION ITEM COMPLETED TAB 44

ACTION ITEM COMPLETED TAB 44 H.B. 1 H.B. 751 Provisions of the H.B. 1 Appropriations Act The base appropriation for TSBP for FY2016-2017 is approximately $234,000 more than the base appropriation the previous biennium. The majority

More information

A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law

A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Knowledge replaces fear. A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Note: Though this article concerns requests made by federal Drug Enforcement Administration investigators

More information

Pursuant to the authority vested in the Commissioner of Health by Article 33 of the

Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health

More information

MONITORING AGREEMENT Overview

MONITORING AGREEMENT Overview MONITORING AGREEMENT Overview Voluntarily agree to participate in the Tennessee Professional Assistance Program (TnPAP) and adhere to the terms set forth in the Monitoring Agreement. Abstinence from Drugs

More information

Discrepancies are claims that appear to have unusual or potentially abusive, wasteful or fraudulent elements (e.g., quantity, days supply).

Discrepancies are claims that appear to have unusual or potentially abusive, wasteful or fraudulent elements (e.g., quantity, days supply). Purpose: Provide guidelines for pharmacies for audits and appeals of pharmacy audit findings resulting from MedImpact auditor data review and claims selection for identification of potential fraud, waste

More information

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-17 GUIDELINES AND STANDARDS FOR THE UTILIZATION OF CONTROLLED SUBSTANCES FOR WEIGHT REDUCTION TABLE OF CONTENTS 540-X-17-.01 540-X-17-.02

More information

RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS

RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED NURSE PRACTITIONERS (CRNP) AND CERTIFIED

More information

TECHNICIAN-IN-TRAING IS NOT PERMITTED TO PRACTICE IN MONTANA IN ANY MANNER WITHOUT AN ACTIVE MONTANA REGISTRATION

TECHNICIAN-IN-TRAING IS NOT PERMITTED TO PRACTICE IN MONTANA IN ANY MANNER WITHOUT AN ACTIVE MONTANA REGISTRATION Page 1 of 8 MONTANA BOARD OF PHARMACY (301 S PARK, 4 TH FLOOR, HELENA, MT 59601 - Delivery) P. O. Box 200513 Helena, Montana 59620-0513 PHONE (406) 841-2300 FAX (406) 841-2344 E-MAIL: dlibsdpha@mt.gov

More information

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations

More information

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics

More information

The Medical Center regrets any inconvenience or problems that the policy may cause but believes that the overall benefit to the institution and its

The Medical Center regrets any inconvenience or problems that the policy may cause but believes that the overall benefit to the institution and its Policy. The following rules represent the University of Mississippi Medical Center s policy concerning substance abuse. They are enforced uniformly with respect to all employees, as indicated: 1. All employees

More information

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies

More information

Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY

Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY 2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...

More information

1 2006. Williams, Kastner & Gibbs PLLC All Rights Reserved

1 2006. Williams, Kastner & Gibbs PLLC All Rights Reserved Drug and Alcohol Records Acquisition and Storage in the Workplace by Kimberly D. Baker Despite the increase in education about and employee assistance directed to the avoidance and treatment of substance

More information

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee) GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;

More information

Unconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35)

Unconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35) Unconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35) Controlled Substance, Drug, Device And Cosmetic Act. 780-113. Prohibited acts; penalties (a) The following acts and the causing thereof

More information

AMERICAN NATIONAL INSURANCE COMPANY CREDIT INSURANCE DIVISION P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 800-899-6502

AMERICAN NATIONAL INSURANCE COMPANY CREDIT INSURANCE DIVISION P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 800-899-6502 P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 DISABILITY CLAIM FORM INSTRUCTIONS Enclosed is a claim form required in order to process disability payments on your loan. It is important that all questions

More information

The following procedures are established in implementation of Policy No. 5530, Substance Abuse.

The following procedures are established in implementation of Policy No. 5530, Substance Abuse. R5530.DR Page 1 of 11 The following procedures are established in implementation of Policy No. 5530,. A. Definitions 1. Evaluation means those procedures used by a certified or licensed professional to

More information

(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose)

(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose) ESSENTIAL ELEMENTS OF AN ELECTRONIC PRESCRIPTION MONITORING PROGRAM There currently is a wide variety of factors that characterize state electronic Prescription Monitoring Programs (PMPs), which originated

More information

Fraud, Waste and Abuse Network Pharmacy Training 2011

Fraud, Waste and Abuse Network Pharmacy Training 2011 Fraud, Waste and Abuse Network Pharmacy Training 2011 Table of Contents Centers for Medicare & Medicaid Services (CMS) Role Important Federal Statutes for Medicare Participants Fraud, Waste and Abuse Defined

More information